$恩佐生化(ENZ)$ 恩佐物化学有限公司(“公司”“我们”、“我们的”或“恩佐”)是一个垂直整合的成长型生物科学公司专注于提供和应用先进技术的能力,以产生廉价可靠的产品和服务让我们的客户,以满足临床需求。We develop, manufacture and sell our proprietary technology solutions and platforms to clinical laboratories, specialty clinics and researchers and physicians globally. 我们开发,生产和销售我们的专有技术解决方案和平台临床实验室、专业诊所和全球研究人员和医生。Enzo’s structure and business strategy represents the culmination of years of extensive planning and work. 恩佐的结构和业务战略代表了多年的广泛的计划和工作的顶峰。The Company now has the unique ability to offer low cost, high performance products and services in molecular diagnostics, which ideally positions it to capitalize on the reimbursement pressures facing diagnostic labs. 公司现在拥有独特的能力提供低成本、高性能的产品和服务在分子诊断,这理想位置利用诊断实验室面临的还款压力。Our pioneering work in genomic analysis coupled with our extensive patent estate and enabling platforms have positioned the Company to continue to play an important role in the rapidly growing molecular medicine marketplaces.我们开创性工作在基因组分析,再加上我们广泛的专利房地产和启用平台定位公司继续发挥重要作用在分子医学市场快速增长。
Enzo technology solutions and platforms and unique operational structure is designed to reduce overall healthcare costs to both government and private insurers.恩佐和独特的技术解决方案和平台运营结构旨在降低整体医疗成本对政府和私人保险公司。Our proprietary technology platforms reduces our customers’ need for multiple, specialized instruments, and offer a variety of throughput capabilities together with a demonstrated high level of accuracy and reproducibility. 我们的专有技术平台降低客户的需要多个专业的仪器,并提供多种吞吐量的能力加上展示高水平的准确性和重现性。Our genetic test panels are focused on large and growing markets primarily in the areas of personalized medicine, women’s health, infectious diseases and genetic disorders.们的基因测试板主要集中在大型和不断增长的市场领域的个性化医学、妇女健康、传染病和遗传病。
For example, our AMPIPROBE® technology platform can lead to the development of an entire line of nucleic acid clinical products that can allow laboratories to offer a complete menu of services at a cost that allows them to enjoy an acceptable margin. 例如,我们AMPIPROBE®技术平台的发展会导致整个核酸的临床产品可以让实验室提供一个完整的菜单的服务成本,让他们享受一个可接受的利润率。Our technology solutions provide tools to physicians, clinicians and other health care providers to improve detection, treatment and monitoring of a broad spectrum of diseases and conditions.我们的技术解决方案提供工具来医生,临床医生和其他健康保健提供者改善检测、治疗和监测广泛的疾病和条件。In addition, reduced patient to physician office visits translates into lower healthcare processing costs and greater patient services.此外,减少病人到医生办公室访问转化为较低的医疗处理成本和更大的病人服务。
In the course of our research and development activities, we have built a substantial portfolio of intellectual property assets, comprising 314 issued patents worldwide, and over 146 pending patent applications, along with extensive enabling technologies and platforms.在我们的研究和开发活动的过程中,我们已经建立了一个实质性的知识产权资产的投资组合,包括314项全球专利发布,和超过146项专利申请,以及广泛的支持技术和平台。
Below are brief descriptions of each of our operating segments (See Note 11 in the Notes to Consolidated Financial Statements):下面简要描述每个操作部分(见注11在合并财务报表附注):
Enzo Clinical Labs is a clinical reference laboratory providing a wide range of clinical services to physicians, medical centers, other clinical labs and pharmaceutical companies. 恩佐临床实验室临床参考实验室提供范围广泛的临床服务医生,医疗中心,其他临床实验室和制药公司。The Company believes having a College of American Pathologists (“CAP”) certified medical laboratory located in New York provides us the opportunity to more rapidly introduce cutting edge products and services to the clinical marketplace. 美国病理学家的公司认为有大学(“帽子”)认证的医学实验室位于纽约提供我们有机会更快的尖端产品和服务介绍给临床市场。Enzo Clinical Labs offers an extensive menu of molecular and other clinical laboratory tests and procedures used in patient care by physicians to establish or support a diagnosis, monitor treatment or medication, and search for an otherwise undiagnosed condition. 恩佐临床实验室提供了一个广泛的菜单的分子和其他临床实验室测试和程序用于病人护理的医生建立或支持诊断、监测治疗或药物治疗,和寻找一个未确诊的条件。Our laboratory is equipped with state of the art communication and connectivity solutions enabling the rapid transmission, analysis and interpretation of generated data. 我们实验室配备了先进的通信和连接解决方案启用快速传播,生成数据的分析和解释。We operate a full service clinical laboratory in Farmingdale, New York, a network of over 30 patient service centers throughout New York and New Jersey, a free standing “STAT” or rapid response laboratory in New York City and a full service phlebotomy, in-house logistics department, and information technology department. 法明岱尔我们操作一个完整的服务临床实验室的纽约,一个网络超过30个病人服务中心在纽约和新泽西,一个独立的“统计”或快速反应实验室在纽约和完整的服务放血,内部物流部门和信息技术部门。Given our license in New York State, we are able to offer testing services to clinical laboratories and physicians in the majority of states nationwide.鉴于我们在纽约州的许可证,我们可以提供测试服务临床实验室和全国绝大多数州的医生。
Enzo Life Sciences manufactures, develops and markets products and tools to clinical research, drug development and bioscience research customers worldwide. 恩佐生命科学生产、开发和市场产品和工具的临床研究,药物开发和生物科学研究全球客户。Underpinned by broad technological capabilities, Enzo Life Sciences has developed proprietary products used in the identification of genomic information by laboratories around the world. 支持广泛的技术能力,恩佐生命科学开发了专利产品用于识别基因组信息世界各地的实验室。Information regarding our technologies can be found in the “Core Technologies” section of our Form 10-K filing for the July 31, 2016 fiscal year. 信息关于我们的技术可以在形式的“核心技术”部分10 - k文件7月31日,2016财政年度。We are internationally recognized and acknowledged as a leader in the development, manufacturing validation and commercialization of numerous products serving not only the clinical research market but life sciences researchers in the fields of cellular analysis and drug discovery, among others. 我们是国际公认的,承认作为一个领导者在开发、生产验证和众多产品的商业化服务不仅临床研究市场,生命科学领域的研究人员细胞分析和药物发现,等等。Our operations are supported by global operations allowing for the efficient marketing and delivery of our products around the world.我们的操作是由全球业务支持允许有效的营销和交付的产品在世界各地。
Enzo Therapeutics is a biopharmaceutical venture that has developed multiple novel approaches in the areas of gastrointestinal, infectious, ophthalmic and metabolic diseases, many of which are derived from the pioneering work of Enzo Life Sciences. 恩佐疗法是一种生物制药企业,开发了多个新方法在胃肠道,传染性,眼科和代谢疾病,其中许多来自生命科学恩佐的开创性工作。Enzo Therapeutics has focused its efforts on developing treatment regimens for diseases and conditions for which current treatment options are ineffective, costly, and/or cause unwanted side effects. 恩佐疗法集中精力发展中疾病和病症的治疗方案,目前的治疗方法是无效的,昂贵的,和/或导致不必要的副作用。This focus has generated a clinical and preclinical pipeline, as well as more than 115 patents and patent applications.这种关注生成的临床和临床前管道,以及超过115项专利和专利申请。